本页面由Tiger Trade Technology Pte. Ltd.提供服务

Travere Therapeutics, Inc.

39.54
-1.4100-3.44%
盘后39.00-0.5400-1.37%19:03 EDT
成交量:456.17万
成交额:1.78亿
市值:36.47亿
市盈率:-138.08
高:40.00
开:39.83
低:38.12
收:40.95
52周最高:43.31
52周最低:13.88
股本:9,224.16万
流通股本:9,122.00万
量比:0.86
换手率:5.00%
股息:- -
股息率:- -
每股收益(TTM):-0.2864
每股收益(LYR):-0.2864
净资产收益率:-57.80%
总资产收益率:-6.55%
市净率:31.76
市盈率(LYR):-138.08

数据加载中...

2025/02/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/13

重要事件披露

Form 8-K - Current report
2024/12/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors